Form 4 for LFMD LifeMD, Inc.
Accepted 2023-08-01 00:00:00 ET · period of report 2022-01-27 · accession 0001362118-23-000049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-08-01 | 2022-01-27+ | LFMD | Mironov Alexander | Pres | A - Grant | — | +100.0K | 74.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-28 | A | A | 50,000 | — | 124,857 | D | — | — | (F2) The shares result from an accelerated vesting of restricted stock. Each restricted stock share is equivalent to one share of the Company's common stock. |
| 2 | Common | Common Stock | 2022-01-27 | A | A | 50,000 | — | 74,857 | D | — | — | (F1) The shares result from the vesting of performance-based restricted stock which vested on January 27, 2022. Each restricted stock share is equivalent to one share of the Company's common stock. |